PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25014183-4	2014	The role of PPARalpha in these pharmacological responses was confirmed by the ability of the PPARalpha antagonist GW6471 (10 muM) to block CLO-, WY14643- and GW7647-induced TRPV1 activation, and by the observation that modulation of PPARalpha levels via siRNA-mediated suppression or PPARalpha over-expression affected TRPV1 channel activation by PPARalpha agonists accordingly.	GW 6471	114-120	peroxisome proliferator-activated receptor alpha	Cricetulus griseus	12-21	
25014183-4	2014	The role of PPARalpha in these pharmacological responses was confirmed by the ability of the PPARalpha antagonist GW6471 (10 muM) to block CLO-, WY14643- and GW7647-induced TRPV1 activation, and by the observation that modulation of PPARalpha levels via siRNA-mediated suppression or PPARalpha over-expression affected TRPV1 channel activation by PPARalpha agonists accordingly.	GW 6471	114-120	peroxisome proliferator-activated receptor alpha	Cricetulus griseus	93-102	
25014183-4	2014	The role of PPARalpha in these pharmacological responses was confirmed by the ability of the PPARalpha antagonist GW6471 (10 muM) to block CLO-, WY14643- and GW7647-induced TRPV1 activation, and by the observation that modulation of PPARalpha levels via siRNA-mediated suppression or PPARalpha over-expression affected TRPV1 channel activation by PPARalpha agonists accordingly.	GW 6471	114-120	peroxisome proliferator-activated receptor alpha	Cricetulus griseus	93-102	
25014183-4	2014	The role of PPARalpha in these pharmacological responses was confirmed by the ability of the PPARalpha antagonist GW6471 (10 muM) to block CLO-, WY14643- and GW7647-induced TRPV1 activation, and by the observation that modulation of PPARalpha levels via siRNA-mediated suppression or PPARalpha over-expression affected TRPV1 channel activation by PPARalpha agonists accordingly.	GW 6471	114-120	peroxisome proliferator-activated receptor alpha	Cricetulus griseus	93-102	
25014183-4	2014	The role of PPARalpha in these pharmacological responses was confirmed by the ability of the PPARalpha antagonist GW6471 (10 muM) to block CLO-, WY14643- and GW7647-induced TRPV1 activation, and by the observation that modulation of PPARalpha levels via siRNA-mediated suppression or PPARalpha over-expression affected TRPV1 channel activation by PPARalpha agonists accordingly.	GW 6471	114-120	peroxisome proliferator-activated receptor alpha	Cricetulus griseus	93-102	
23083124-7	2013	The TRPV1 antagonists capsazepine (1 muM) and SB-366791 (1 muM), as well as the PPARalpha antagonist GW-6471 (10 muM), inhibited PEA-induced [Ca2+](i) increase; blockers of cannabinoid receptors were ineffective.	GW 6471	101-108	peroxisome proliferator-activated receptor alpha	Cricetulus griseus	80-89